E3 ligases

#E3 ligases #Investment #Life sciences #Neurodegenerative disorders #TRIMTECH Therapeutics

Part 1: A day exploring Cambridge’s life science scene

DDW’s Megan Thomas went to Cambridge, UK, to learn more about what’s happening in this life science epicentre. She spoke with a number of local companies and attended events, the first of which she writes about here: A conversation with Nicola Thompson, CEO of TRIMTECH Therapeutics. E3 ligases to expand… Read More

#Business & Investment #Exclusive Content